Alzinova announces biomarker collaboration with Sahlgrenska University Hospital Alzinova is collaborating with prominent researchers at Sahlgrenska University Hospital in Gothenburg, Sweden, to track markers of neurodegenerative change in Alzheimer’s disease. Read More PressreleaseMelisha LinnellFebruary 19, 2021Life Science, Alzheimers, biopharma, Henrik Zetterberg, biomarker, Sahlgrenska University, Hospital, Vaccine, Kaj Blennow, Alzinova, GU Ventures, Kristina Torfgård, neurochemistry
